Scynexis
Price & Volume
Stats
See more52W Range | $0.66-$1.62 |
Market Cap | $45M |
Shares Short | 674,367 |
Financials
See moreRevenue (12 Mos) | $3.2M |
Revenue Growth (YoY) | 85.3% |
Gross Profit (12 Mos) | $3.2M |
Diluted EPS | -$0.40 |
News
See moreYahoo Finance • 25 days ago
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
Yahoo Finance • 2 months ago
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 4 months ago
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
Yahoo Finance • 4 months ago
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Dr. David Gonzalez Angulo M.D. |
Address | 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 28 |
